ATG5 as biomarker for early detection of malignant mesothelioma

0571546 - BTÚ 2024 RIV DE eng J - Článek v odborném periodiku
Tomasetti, M. - Monaco, F. - Strogovets, O. - Volpini, L. - Valentino, M. - Amati, M. - Neužil, Jiří - Santarelli, L.
ATG5 as biomarker for early detection of malignant mesothelioma.
BMC Research Notes. Roč. 16, č. 1 (2023), č. článku 61. ISSN 1756-0500
Institucionální podpora: RVO:86652036
Klíčová slova: Asbestos exposure * Malignant pleural mesothelioma * atg5 * hmgb1 * miRNAs * Biomarkers
Obor OECD: Biochemistry and molecular biology
Impakt faktor: 1.8, rok: 2022
Způsob publikování: Open access
https://bmcresnotes.biomedcentral.com/articles/10.1186/s13104-023-06330-1

ObjectivesMalignant pleural mesothelioma (MPM) is an aggressive disease with grim prognosis due to lack of effective treatment options. Disease prediction in association with early diagnosis may both contribute to improved MPM survival. Inflammation and autophagy are two processes associated with asbestos-induced transformation. We evaluated the level of two autophagic factors ATG5 and HMGB1, microRNAs (miRNAs) such as miR-126 and miR-222, and the specific biomarker of MPM, soluble mesothelin related proteins (Mesothelin) in asbestos-exposed individuals, MPM patients, and healthy subjects. The performance of these markers in detecting MPM was investigated in pre-diagnostic samples of asbestos-subjects who developed MPM during the follow-up and compared for the three groups.ResultsThe ATG5 best distinguished the asbestos-exposed subjects with and without MPM, while miR-126 and Mesothelin were found as a significant prognostic biomarker for MPM. ATG5 has been identified as an asbestos-related biomarker that can help to detect MPM with high sensitivity and specificity in pre-diagnostic samples for up to two years before diagnosis. To utilize this approach practically, higher number of cases has to be tested in order to give the combination of the two markers sufficient statistical power. Performance of the biomarkers should be confirmed by testing their combination in an independent cohort with pre-diagnostic samples.
Trvalý link: https://hdl.handle.net/11104/0343066